ArticleInternational journal of ophthalmology2025
Visual function in the diagnosis of multiple sclerosis and optic neuritis.
Article in International journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo determine the diagnostic ability of various visual functions in patients with multiple sclerosis (MS) with and without optic neuritis (ON).
methodsIn this cross-sectional study, we assessed and compared refractive error, visual acuity (VA), and contrast sensitivity (CS) between patients with MS and a matched control group of healthy individuals. The MS patients were further categorized into those with ON and those without.
resultsA total of 133 eyes from 133 participants were assessed, including 66 individuals diagnosed with MS. The mean ages for the MS group and the healthy control group were 37.5±4.27y and 38.45±4.60y, respectively (
conclusionMS significantly affects refractive error and CS, with ON further reducing CS. Assessing these visual parameters can improve MS monitoring and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.